FDA Cites Single-Use Reprocessor For 17 QS/GMP Violations

Visions in Endosurgery, Inc.' s "failure to develop, conduct, control, and monitor production processes involving the reprocessing of single-use and reusable devices" is cited by FDA in a Jan. 6 warning letter to the Port Orange, Florida reprocessing facility.